Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 86

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of peginterferon alfa-2b for chronic myeloid leukemia and essential thrombocythemia during pregnancy

Ziyu Wen, Xuan Zhou, Bingyu Lin, Qiang WANG, Liping Ma, Huilan Zeng, Zhi Liu, Bolin He, Qing Zhang, Mei Zhong, Xiaoli Liu, Na Xu

Blood (2025) 146 (Supplement 1): 7358.

https://doi.org/10.1182/blood-2025-7358

Published: 2025

Journal Articles

A mammalian coacervate-based platform for high-efficiency gene editing in hematopoietic stem cells

Renxia Zhang, Peipei Zhu, Manman Lu, Qing Zhang, Xiaoqian Nie, Hsiang-Ying Lee, Xiaofei Gao

Blood (2025) 146 (Supplement 1): 4186.

https://doi.org/10.1182/blood-2025-4186

Published: 2025

Journal Articles

Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT Induces Durable Remissions in PD-(L)1 inhibitor-resistant Refractory/relapsed classical Hodgkin lymphoma: A single-center, long-term study

Xingchen Liu, Qing Zhang, Hao Guo, Qianying Pan, Keshu Zhou

Blood (2025) 146 (Supplement 1): 1847.

https://doi.org/10.1182/blood-2025-1847

Published: 2025

Journal Articles

Zanubrutinib combined with anti-CD19 CAR-T cell therapy in relapsed and refractory B-cell lymphoma

Xiangmin Wang, Qing Zhang, Yujie Li, Ruiyang Xie, Yawen Wei, Kang Rong, Xicheng Chen, Linyan Xu, Dongmei Yan, Kailin Xu, Wei Sang

Blood (2025) 146 (Supplement 1): 7233.

https://doi.org/10.1182/blood-2025-7233

Published: 2025

Journal Articles

Peripheral blood B-cell early regeneration predicts clinical relapse and guides preemptive therapy after CAR-T treatment in acute lymphoblastic leukemia

Jiamin Yao, Qing Zhang, Fan Wu, Yingwei Li, Lili Tao, Huiping Wang, Zhimin Zhai, Furun An, Qianshan Tao

Blood (2025) 146 (Supplement 1): 6882.

https://doi.org/10.1182/blood-2025-6882

Published: 2025

Journal Articles

Efficacy and safety of zanubrutinib-containing regimens in patients with newly diagnosed Mantle Cell Lymphoma: Interim results from a Phase II investigator-initiated study

Blood (2025) 146 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2025-1823

Published: 2025

Journal Articles

MRC2: A tumor-restricted surface antigen for immunotherapy in Acute Myeloid Leukemia

Ruotong Chen, Wanqiu Zhang, Caixian Xu, Qing Zhang, Huiping Wang, Zhimin Zhai, Qianshan Tao

Blood (2025) 146 (Supplement 1): 3291.

https://doi.org/10.1182/blood-2025-3291

Published: 2025

Journal Articles

The preliminary results of MRG001-C002: A phase II Study of MRG001 combined with Orelabrutinib in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Keshu Zhou, Xingchen Liu, Xueli Jiao, Qing Zhang, xu Ji, Qianying Pan, Kai Hu, Bian Wei, Lin Chen, Fenghua Gao, Minghui Li, Quande Lin, Ruihua Mi, Fengdi Wang, Haiying Wang, Qinglan Zhang, Lihua Dong

Blood (2025) 146 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2025-1914

Published: 2025

Journal Articles

A mammalian protein-based coacervate platform enables scalable engineering for CAR-T therapy

Peipei Zhu, Manman Lu, Qing Zhang, Renxia Zhang, Lihong Jiang, Xiaoqian Nie, Hsiang-Ying Lee, Xiaofei Gao

Blood (2025) 146 (Supplement 1): 7622.

https://doi.org/10.1182/blood-2025-7622

Published: 2025

Journal Articles

Efficacy and safety of polatuzumab vedotin-based regimens for elderly/frail DLBCL patients: A real-world study

Xingchen Liu, Qing Zhang, Qianying Pan, Xueli Jiao, Fenghua Gao, Lihua Dong, Zhihua Yao, Keshu Zhou

Blood (2025) 146 (Supplement 1): 5470.

https://doi.org/10.1182/blood-2025-5470

Published: 2025

Journal Articles

Targeting the ARHGAP18/PI3K/AKT axis with vincristine and cytarabine synergistically suppresses senescence and induces apoptosis in AML

Haotian Yan, Wenjie Dai, Qing Zhang, Huiping Wang, Zhimin Zhai, Ruijun Yang, Qianshan Tao

Blood (2025) 146 (Supplement 1): 6806.

https://doi.org/10.1182/blood-2025-6806

Published: 2025

Journal Articles

Efficacy and Safety of Combined Anti-PD-1, Bortezomib and Pegaspargase Regimen for Newly Diagnosed Early Stage Extranodal NK/T-Cell Lymphoma

Xiangmin Wang, Qing Zhang, Yujie Li, Ruiyang Xie, Hongyuan Zhou, Xicheng Chen, Linyan Xu, Jianlin Qiao, Dongmei Yan, Kailin Xu, Wei Sang

Blood (2024) 144 (Supplement 1): 6412.

https://doi.org/10.1182/blood-2024-207344

Published: 2024

Journal Articles

Construction and Validation of the New Prognostic Model Based on Genetic Risk Stratification for Chinese AML Patients

Fengli Li, Yangyang Ding, Shanglong Feng, Beibei Xie, Xunyi Jiao, Jinli Zhu, Qing Zhang, Qianshan Tao, Huiping Wang, Xin Liu, Depei Wu, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 6164.

https://doi.org/10.1182/blood-2024-210615

Published: 2024

Journal Articles

Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence

Xiyang Ren, Haotian Yan, Mei Zhou, Fan Wu, Qing Zhang, Yangyang Ding, Qian Li, Huiping Wang, Caixian Xu, Jiyu Wang, Cong Li, Wanqiu Zhang, Linlin Liu, Ruotong Chen, Yi Dong, Wenjie Dai, Zhimin Zhai, Qianshan Tao

Blood (2024) 144 (Supplement 1): 2754.

https://doi.org/10.1182/blood-2024-205440

Published: 2024

Journal Articles

Analysis of the Impact of TKI Dose Adjustment Under the Guidance of Blood Concentration Monitoring on the Efficacy, Safety and Quality of Life in Patients with CML

Zherou He, Qing Zhang, Xuan Zhou, Qiang Wang, Xiaoli Liu, Na Xu

Blood (2024) 144 (Supplement 1): 1773.

https://doi.org/10.1182/blood-2024-207302

Published: 2024

Journal Articles

DCAF13 Is Essential for Hematopoietic Stem Cell Function By Stabilization of Ribosome Biogenesis and P53 Pathway

Mengke Li, Yuxin Wu, Qing Zhang, Shuai Zhou, Rui Zhang, Shengnan Yuan, YingYing Wang, Huan Zhao, Wenyi Lu, Xiaojing Shi, Dongping Wei, Zunmin Zhu, Song Chen

Blood (2024) 144 (Supplement 1): 2651.

https://doi.org/10.1182/blood-2024-198288

Published: 2024

Journal Articles

Efficient Generation of CAR-T By the First Coacervate-Based Gene Delivery System

Peipei Zhu, Xiaofei Gao, Yang Yuan, Manman Lu, Qing Zhang, Menghao Ding, Lihong Jiang, Yaohuang Huang, Hsiang-Ying Lee

Blood (2024) 144 (Supplement 1): 150.

https://doi.org/10.1182/blood-2024-202981

Published: 2024

Journal Articles

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Qing Zhang, Yun-Ze Zhao, Hong-Hao Ma, Dong Wang, Lei Cui, Wei-Jing Li, Ang Wei, Chan-Juan Wang, Tian-You Wang, Zhi-Gang Li, Rui Zhang

Blood (2022) 139 (24): 3493–3504.

https://doi.org/10.1182/blood.2021014860

Published: 2022

Includes: Supplemental data

Journal Articles

Clinical Study on the CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Acute Lymphoblast Leukemia: A Single Center of Real World Data

Jing Huang, Zhi Liu, Ruiming Ou, Liling Zheng, Yangmin Zhu, Yuanyuan Du, Qinjun Zhou, Jia Fei, Shuang Liu, Qing Zhang

Blood (2021) 138 (Supplement 1): 4834.

https://doi.org/10.1182/blood-2021-149443

Published: 2021

Journal Articles

Efficacy and Safety of CD19-Targeted CAR-T Cell Therapy for Refractory/Relapsed B-Cell Lymphoma: A Single Center of Real World Data

Jing Huang, Jia Fei, Ruiming Ou, Zhi Liu, Liling Zheng, Yangmin Zhu, Huijuan Shen, Yuanyuan Du, Qinjun Zhou, Jiali Chen, Changhua Zhou, Rongrong Yan, Jiale Wang, Shuang Liu, Qing Zhang

Blood (2021) 138 (Supplement 1): 4827.

https://doi.org/10.1182/blood-2021-144997

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy and safety of peginterferon alfa-2b for chronic myeloid leukemia and essential thrombocythemia during pregnancy

A mammalian coacervate-based platform for high-efficiency gene editing in hematopoietic stem cells

Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT Induces Durable Remissions in PD-(L)1 inhibitor-resistant Refractory/relapsed classical Hodgkin lymphoma: A single-center, long-term study

Zanubrutinib combined with anti-CD19 CAR-T cell therapy in relapsed and refractory B-cell lymphoma

Peripheral blood B-cell early regeneration predicts clinical relapse and guides preemptive therapy after CAR-T treatment in acute lymphoblastic leukemia

Efficacy and safety of zanubrutinib-containing regimens in patients with newly diagnosed Mantle Cell Lymphoma: Interim results from a Phase II investigator-initiated study

MRC2: A tumor-restricted surface antigen for immunotherapy in Acute Myeloid Leukemia

The preliminary results of MRG001-C002: A phase II Study of MRG001 combined with Orelabrutinib in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

A mammalian protein-based coacervate platform enables scalable engineering for CAR-T therapy

Efficacy and safety of polatuzumab vedotin-based regimens for elderly/frail DLBCL patients: A real-world study

Targeting the ARHGAP18/PI3K/AKT axis with vincristine and cytarabine synergistically suppresses senescence and induces apoptosis in AML

Efficacy and Safety of Combined Anti-PD-1, Bortezomib and Pegaspargase Regimen for Newly Diagnosed Early Stage Extranodal NK/T-Cell Lymphoma

Construction and Validation of the New Prognostic Model Based on Genetic Risk Stratification for Chinese AML Patients

Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence

Analysis of the Impact of TKI Dose Adjustment Under the Guidance of Blood Concentration Monitoring on the Efficacy, Safety and Quality of Life in Patients with CML

DCAF13 Is Essential for Hematopoietic Stem Cell Function By Stabilization of Ribosome Biogenesis and P53 Pathway

Efficient Generation of CAR-T By the First Coacervate-Based Gene Delivery System

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Clinical Study on the CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Acute Lymphoblast Leukemia: A Single Center of Real World Data

Efficacy and Safety of CD19-Targeted CAR-T Cell Therapy for Refractory/Relapsed B-Cell Lymphoma: A Single Center of Real World Data

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only